Botulinum Toxin Type A

CHEMBL4297862 Phase 4 Onaylandı Protein

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

— g/mol

LogP

—

Phase

4

A purified form of the toxin produced by Clostridium botulinum bacteria, used in tiny, precise doses to temporarily paralyze specific muscles. It is used therapeutically for conditions such as cervical dystonia, chronic migraine, excessive sweating, overactive bladder, and cosmetically to reduce facial wrinkles. Effects last for several months before repeat treatment is needed.

Terapötik Alanlar

Benign Prostatic Hyperplasia Cardiovascular Disease Respiratory Disease Pain Management Rheumatoid Arthritis Chronic Obstructive Pulmonary Disease Alzheimer's Disease Parkinson's Disease Migraine Generalized Anxiety Disorder Infectious Disease Gastroesophageal Reflux Disease Inflammatory Bowel Disease Psoriasis Multiple Sclerosis Chronic Kidney Disease Non-Alcoholic Fatty Liver Disease Stroke Obesity Major Depressive Disorder Breast Cancer Atopic Dermatitis Chronic Pain Atrial Fibrillation Prostate Cancer Colorectal Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A purified form of the toxin produced by Clostridium botulinum bacteria, used in tiny, precise doses to temporarily paralyze specific muscles. It is used therapeutically for conditions such as cervical dystonia, chronic migraine, excessive sweating, overactive bladder, and cosmetically to reduce facial wrinkles. Effects last for several months before repeat treatment is needed.

Yes, Botulinum Toxin Type A is an approved drug. It has reached clinical phase 4. It is classified as a Protein.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4297862. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Botulinum Toxin Type A PillFYI'da

Hızlı Veriler

Eş Anlamlılar: 3

Dış Bağlantılar

ChEMBL CHEMBL4297862

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.